Tower Research Capital (TRC)’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.23K | Buy |
+23,316
| New | +$9.23K | ﹤0.01% | 3996 |
|
|
2025
Q1 | – | Sell |
-5,939
| Closed | -$3.51K | – | 5195 |
|
|
2024
Q4 | $3.51K | Buy |
5,939
+804
| +16% | +$475 | ﹤0.01% | 4646 |
|
|
2024
Q3 | $9.04K | Sell |
5,135
-12,736
| -71% | -$22.4K | ﹤0.01% | 3912 |
|
|
2024
Q2 | $24.5K | Buy |
17,871
+16,370
| +1,091% | +$22.4K | ﹤0.01% | 3641 |
|
|
2024
Q1 | $5.16K | Sell |
1,501
-3,418
| -69% | -$11.8K | ﹤0.01% | 4579 |
|
|
2023
Q4 | $12.1K | Sell |
4,919
-2,796
| -36% | -$6.88K | ﹤0.01% | 4075 |
|
|
2023
Q3 | $13.1K | Buy |
7,715
+3,065
| +66% | +$5.21K | ﹤0.01% | 3828 |
|
|
2023
Q2 | $14K | Sell |
4,650
-6,645
| -59% | -$19.9K | ﹤0.01% | 3708 |
|
|
2023
Q1 | $30K | Buy |
11,295
+4,711
| +72% | +$12.5K | ﹤0.01% | 2983 |
|
|
2022
Q4 | $54K | Buy |
6,584
+4,579
| +228% | +$37.6K | ﹤0.01% | 2286 |
|
|
2022
Q3 | $15K | Sell |
2,005
-3,089
| -61% | -$23.1K | ﹤0.01% | 4154 |
|
|
2022
Q2 | $14K | Sell |
5,094
-2,452
| -32% | -$6.74K | ﹤0.01% | 4127 |
|
|
2022
Q1 | $37K | Buy |
7,546
+3,253
| +76% | +$16K | ﹤0.01% | 2955 |
|
|
2021
Q4 | $84K | Buy |
4,293
+1,487
| +53% | +$29.1K | ﹤0.01% | 2346 |
|
|
2021
Q3 | $83K | Buy |
2,806
+2,326
| +485% | +$68.8K | ﹤0.01% | 2544 |
|
|
2021
Q2 | $20K | Sell |
480
-1,013
| -68% | -$42.2K | ﹤0.01% | 3871 |
|
|
2021
Q1 | $76K | Buy |
+1,493
| New | +$76K | ﹤0.01% | 2792 |
|